KUDOS PHARMACEUTICALS LIMITED
Get an alert when KUDOS PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£813m
-51% lowest in 3 filed years
Employees
—
Average over period
Profit before tax
£145m
-79.4% lowest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £670,000,000 | £980,000,000 | £523,000,000 | -46.6% | |
| Operating profit | £853,000,000 | £633,000,000 | £102,000,000 | -83.9% | |
| Profit before tax | £856,000,000 | £705,000,000 | £145,000,000 | -79.4% | |
| Net profit | £813,000,000 | £634,000,000 | £155,000,000 | -75.6% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £1,017,000,000 | £1,673,000,000 | — | — | |
| Net assets | £1,024,000,000 | £1,658,000,000 | £813,000,000 | -51% | |
| Equity | £1,024,000,000 | £1,658,000,000 | £813,000,000 | -51% | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 127.3% | 64.6% | 19.5% | |
| Net margin | 121.3% | 64.7% | 29.6% | |
| Return on capital employed | 83.9% | 37.8% | — | |
| Gearing (liabilities / total assets) | 16.3% | 12.1% | 32.0% | |
| Current ratio | 7.52x | 10.44x | 6.44x | |
| Interest cover | 65.62x | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Based on their assessment of the Company's financial position, they continue to adopt the going concern basis in preparing the Financial Statements.”
Significant events
- “In June 2024, AstraZeneca was served with a lawsuit filed by the University of Sheffield (Sheffield). In its complaint, Sheffield alleged that AstraZeneca made misrepresentations to induce Sheffield to agree to amend a patent licence agreement relating to Lynparza. In May 2026, AstraZeneca entered into a global settlement agreement with Sheffield that resolves all disputes between the parties relating to Lynparza. As at 31 December 2025, a provision has been recorded totalling £163m ($220m), payable within the one year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
8 active · 30 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSTONE, Camilla Jane | Secretary | 2019-09-16 | — | — |
| BOWDEN, Matthew Shaun | Director | 2019-02-27 | Dec 1977 | British |
| COLLINS, Iain Alistair | Director | 2017-05-31 | Dec 1970 | British |
| GALBRAITH, Susan | Director | 2024-06-28 | Oct 1965 | British |
| SAMBROOK, Sally | Director | 2024-06-28 | Feb 1973 | British |
| SARIN, Aradhana | Director | 2024-06-28 | Apr 1974 | American |
| STEPHENS, Christine | Director | 2024-06-28 | Apr 1971 | British |
| TATTERSALL, Hannah Victoria | Director | 2025-05-01 | Jul 1987 | British |
Show 30 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURR, Kenneth Edward | Secretary | 1999-03-09 | 2002-03-04 |
| CONACHER, Matthew Ian | Secretary | 2017-03-16 | 2019-09-16 |
| DALLY, David James Michael | Secretary | 2002-03-04 | 2006-01-31 |
| HOSKINS, Justin Wilbert | Secretary | 2006-11-20 | 2011-12-16 |
| JACKSON-TURNER, Katie Louise | Secretary | 2015-07-15 | 2017-03-16 |
| KEMP, Adrian Charles Noel | Secretary | 2006-01-31 | 2006-11-20 |
| O'GRADY, Claire-Marie | Secretary | 2011-12-16 | 2015-07-31 |
| WALLACE, Roderick Iain | Secretary | 1997-12-12 | 1999-03-09 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1997-12-12 | 1997-12-12 |
| AUTY, Richard Maitland, Dr | Director | 2003-03-19 | 2006-01-31 |
| BENJAMIN, Jerry Christopher | Director | 1999-03-02 | 2000-06-30 |
| BLUNDY, Keith Stuart, Dr | Director | 1999-12-17 | 2002-08-28 |
| BRIMICOMBE, Ian Martin David | Director | 2006-01-31 | 2017-05-31 |
| CARTER, Michael Greenwood, Doctor | Director | 1999-03-02 | 2006-01-31 |
| FODEN, Susan Elizabeth, Dr | Director | 1997-12-12 | 1999-11-10 |
| JACKSON, Stephen Philip | Director | 1997-12-12 | 2006-01-31 |
| JACKSON-TURNER, Katie Louise | Director | 2017-03-16 | 2019-02-27 |
| JENNINGS, Richard Charles, Dr | Director | 1997-12-12 | 1999-03-02 |
| KEMP, Adrian Charles Noel | Director | 2009-01-01 | 2025-05-01 |
| KUIJTEN, Rene Robert | Director | 2002-08-28 | 2006-01-31 |
| LAMBERT, Susan | Director | 2002-08-28 | 2003-11-05 |
| LEE, Patrick Pak Tin | Director | 2000-07-01 | 2006-01-31 |
| LONG, Ronald Eric | Director | 2001-01-01 | 2006-01-31 |
| MANSFORD, Keith, Doctor | Director | 1997-12-12 | 2001-01-01 |
| MUSKER, Graeme Harold Rankine | Director | 2006-01-31 | 2008-12-31 |
| PETTY, Cathrin | Director | 1999-03-02 | 2000-05-09 |
| THURSTON, Julian Paul | Director | 1997-12-12 | 1998-10-30 |
| WARD, John Barrie, Dr | Director | 1999-03-02 | 2006-01-31 |
| WHITAKER, Raymond, Dr | Director | 2002-08-28 | 2006-01-31 |
| ZEHAVI, Zeev | Director | 2003-11-05 | 2006-01-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Astrazeneca Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 224 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-11-27 RESOLUTIONS Resolution
- 2024-11-27 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-07 | AA | accounts | Accounts with accounts type full | |
| 2025-12-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-07 | AA | accounts | Accounts with accounts type full | |
| 2025-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-27 | MA | incorporation | Memorandum articles | |
| 2024-08-28 | CH01 | officers | Change person director company with change date | |
| 2024-08-02 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-14 | AA | accounts | Accounts with accounts type full | |
| 2022-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-16 | CH01 | officers | Change person director company with change date | |
| 2022-08-05 | AA | accounts | Accounts with accounts type full | |
| 2021-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.